FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "QuVa Pharma, Inc.(079937015)" | 70092-259 | 70092-259-75 | Ropivacaine Hydrochloride; Fentanyl Citrate | 200 mg/100 mL; 200 ug/100 mL | 2026-1 | valid | 2026-10-06 | ||
| QuVa Pharma, Inc. | 70092-259 | 70092-259-75 | Fent 2mcg/mL-Rop 0.2% PF 100ml NS CADDYFS | Fent 2mcg/mL-Rop 0.2% PF 100ml NS CADDYFS | 200 mg/100 mL; 200 ug/100 mL | 2026-1 | valid | 2026-09-18 | |
| "QuVa Pharma, Inc.(079937015)" | 70092-259 | 70092-259-75 | Ropivacaine Hydrochloride; Fentanyl Citrate | 200 mg/100 mL; 200 ug/100 mL | 2025-2 | valid | 2026-10-06 | ||
| QuVa Pharma, Inc. | 70092-259 | 70092-259-75 | Fent 2mcg/mL-Rop 0.2% PF 100ml NS CADDYFS | Fent 2mcg/mL-Rop 0.2% PF 100ml NS CADDYFS | 200 mg/100 mL; 200 ug/100 mL | 2025-2 | valid | 2026-09-18 | |
| "QuVa Pharma, Inc.(079937015)" | 70092-259 | 70092-259-75 | Ropivacaine Hydrochloride; Fentanyl Citrate | 200 mg/100 mL; 200 ug/100 mL | 2025-1 | valid | 2026-10-06 | ||
| QuVa Pharma, Inc. | 70092-259 | 70092-259-75 | Fent 2mcg/mL-Rop 0.2% PF 100ml NS CADD-Y | Fent 2mcg/mL-Rop 0.2% PF 100ml NS CADD-Y | 200 mg/100 mL; 200 ug/100 mL | 2025-1 | valid | 2026-09-18 | |
| "QuVa Pharma, Inc.(079937015)" | 70092-259 | 70092-259-75 | Ropivacaine Hydrochloride; Fentanyl Citrate | 200 mg/100 mL; 200 ug/100 mL | 2024-2 | valid | 2026-10-06 | ||
| QuVa Pharma, Inc. | 70092-259 | 70092-259-75 | Fent 2mcg/mL-Rop 0.2% PF 100ml NS CADD-Y | Fent 2mcg/mL-Rop 0.2% PF 100ml NS CADD-Y | 200 mg/100 mL; 200 ug/100 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma | 079937015 | 70092-259 | 70092-259-75 | Ropivacaine Hydrochloride; Fentanyl Citrate | 200 mg/100 mL; 200 ug/100 mL | 2024-1 | valid | 2026-10-06 | |
| QuVa Pharma | 079937015 | 70092-259 | 70092-259-75 | Ropivacaine Hydrochloride; Fentanyl Citrate | 200 mg/100 mL; 200 ug/100 mL | 2023-2 | valid | 2026-10-06 | |
| QuVa Pharma | 079937015 | 70092-259 | 70092-259-75 | Ropivacaine Hydrochloride; Fentanyl Citrate | 200 mg/100 mL; 200 ug/100 mL | 2023-1 | valid | 2026-10-06 | |
| QuVa Pharma | 079937015 | 70092-259 | 70092-259-75 | Ropivacaine Hydrochloride; Fentanyl Citrate | 200 mg/100 mL; 200 ug/100 mL | 2022-2 | valid | 2026-10-06 | |
| QuVa Pharma | 079937015 | 70092-259 | 70092-259-75 | Ropivacaine Hydrochloride; Fentanyl Citrate | 200 mg/100 mL; 200 ug/100 mL | 2022-1 | valid | 2026-10-06 |